Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.
Share or print this source review
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.
Clinical context remains essential
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
Check source scope before reading a dose
Montelukast 10 mg tablets (adults) - selected U.S. labeling
Product / population
Adult asthma maintenance with oral 10 mg film-coated montelukast tablets. Excludes pediatric strengths and acute rescue treatment.
Renal method
Qualitative renal guidance; no numeric renal function algorithm.
Source revision
Label revision date not separately recorded; retrieval date is not the revision date.
Retrieved
2026-09-05
Local review status
Selected dosing/renal sections read; concise local summary, not full prescribing information.
Official
Montelukast 10 mg tablets (adults) - selected U.S. labeling
U.S. product labeling / DailyMed · Adult asthma maintenance with oral 10 mg film-coated montelukast tablets. Excludes pediatric strengths and acute rescue treatment.
Renal method: Qualitative renal guidance; no numeric renal function algorithm. Source date: Label revision date not separately recorded; retrieval date is not the revision date. Retrieved: 2026-09-05
Selected dosing/renal sections read; concise local summary, not full prescribing information.
Labeled basic dosing
For asthma maintenance, give 10 mg orally once each evening. This is not treatment for an acute asthma attack.
The label recommends no dose change for renal insufficiency. Whether montelukast is removed by hemodialysis or peritoneal dialysis is unknown in the label.
Boxed warning: serious neuropsychiatric events, including suicidal thoughts or behavior. Discuss risks, stop the drug and contact a clinician promptly for new symptoms. For allergic rhinitis, reserve use for inadequate response or intolerance to alternatives.
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
GlobalRPh v6.6 | RDM66-DIRECT-PHP-20260911 | Local library date 2026-09-11. Selected-card identity does not imply clinical verification.